235 related articles for article (PubMed ID: 25982423)
1. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
2. Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.
Say EA; Iyer PG; Hasanreisoglu M; Lally SE; Jabbour P; Shields JA; Shields CL
J AAPOS; 2016 Aug; 20(4):337-42. PubMed ID: 27328850
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial chemotherapy for retinoblastoma: Two-year results from tertiary eye-care center in India.
Rishi P; Sharma T; Sharma M; Maitray A; Dhami A; Aggarwal V; Munusamy S; Ravikumar R; Ramamurthy S
Indian J Ophthalmol; 2017 Apr; 65(4):311-315. PubMed ID: 28513496
[TBL] [Abstract][Full Text] [Related]
4. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
[TBL] [Abstract][Full Text] [Related]
5. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.
Tuncer S; Sencer S; Kebudi R; Tanyıldız B; Cebeci Z; Aydın K
Acta Ophthalmol; 2016 Nov; 94(7):e644-e651. PubMed ID: 27214798
[TBL] [Abstract][Full Text] [Related]
6. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
[TBL] [Abstract][Full Text] [Related]
7. Globe Salvage With Intra-Arterial Topotecan-Melphalan Chemotherapy in Children With a Single Eye.
Leal-Leal CA; Asencio-López L; Higuera-Calleja J; Bernal-Moreno M; Bosch-Canto V; Chávez-Pacheco J; Isaac-Otero G; Beck-Popovic M
Rev Invest Clin; 2016; 68(3):137-42. PubMed ID: 27409000
[TBL] [Abstract][Full Text] [Related]
8. First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of treatment.
Munier FL; Mosimann P; Puccinelli F; Gaillard MC; Stathopoulos C; Houghton S; Bergin C; Beck-Popovic M
Br J Ophthalmol; 2017 Aug; 101(8):1086-1093. PubMed ID: 27927678
[TBL] [Abstract][Full Text] [Related]
9. RHEGMATOGENOUS RETINAL DETACHMENT AFTER INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: The 2016 Founders Award Lecture.
Shields CL; Say EAT; Pefkianaki M; Regillo CD; Caywood EH; Jabbour PM; Shields JA
Retina; 2017 Aug; 37(8):1441-1450. PubMed ID: 27787452
[TBL] [Abstract][Full Text] [Related]
10. Successful conservative treatment of massive choroidal relapse in 2 retinoblastoma patients monitored by ultrasound biomicroscopy and/or spectral domain optic coherence tomography.
Stathopoulos C; Gaillard MC; Puccinelli F; Maeder P; Hadjistilianou D; Beck-Popovic M; Munier FL
Ophthalmic Genet; 2018 Apr; 39(2):242-246. PubMed ID: 29099668
[TBL] [Abstract][Full Text] [Related]
11. Outcome of intra-arterial chemotherapy for retinoblastoma and its influencing factors: a retrospective study.
Chen M; Jiang H; Zhang J; Shen G; Jiang Y; Li H; Liu Z
Acta Ophthalmol; 2017 Sep; 95(6):613-618. PubMed ID: 27874261
[TBL] [Abstract][Full Text] [Related]
12. Angiographic characteristics and treatment approach in patients undergoing intra-arterial chemotherapy for retinoblastoma.
Rusakevich AM; Nahhas MI; Zhou B; Dannenbaum MJ; Bretana ME; Schefler AC
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; 262(4):1321-1328. PubMed ID: 38032379
[TBL] [Abstract][Full Text] [Related]
13. Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma.
Reddy MA; Naeem Z; Duncan C; Robertson F; Herod J; Rennie A; Liasis A; Thompson DA; Sagoo M
Br J Ophthalmol; 2017 Dec; 101(12):1704-1708. PubMed ID: 28432112
[TBL] [Abstract][Full Text] [Related]
14. Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis.
Fabian ID; Stacey AW; Johnson KP; Onadim Z; Chowdhury T; Duncan C; Reddy MA; Sagoo MS
Br J Ophthalmol; 2017 Jan; 101(1):82-88. PubMed ID: 27965263
[TBL] [Abstract][Full Text] [Related]
15. Intra-Arterial Chemotherapy as Primary Therapy for Retinoblastoma in Infants Less than 3 Months of Age: A Series of 10 Case-Studies.
Chen M; Zhao J; Xia J; Liu Z; Jiang H; Shen G; Li H; Jiang Y; Zhang J
PLoS One; 2016; 11(8):e0160873. PubMed ID: 27504917
[TBL] [Abstract][Full Text] [Related]
16. Globe salvage treatment in group D and group E retinoblastoma.
Hussain AK; Rahul RA; Carlos RL; Francisco ZM; María GL; Flavia P; Chiara B; Davide B
Rom J Ophthalmol; 2021; 65(1):20-24. PubMed ID: 33817429
[No Abstract] [Full Text] [Related]
17. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.
Berry JL; Shah S; Bechtold M; Zolfaghari E; Jubran R; Kim JW
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28646513
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of secondary epipapillary retinoblastoma.
Fabian ID; Puccinelli F; Gaillard MC; Beck-Popovic M; Munier FL
Br J Ophthalmol; 2017 Oct; 101(10):1412-1418. PubMed ID: 28183830
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.
Abramson DH; Fabius AW; Francis JH; Marr BP; Dunkel IJ; Brodie SE; Escuder A; Gobin YP
Ophthalmic Genet; 2017; 38(1):16-21. PubMed ID: 28095092
[TBL] [Abstract][Full Text] [Related]
20. Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.
Francis JH; Iyer S; Gobin YP; Brodie SE; Abramson DH
Ophthalmology; 2017 Oct; 124(10):1548-1555. PubMed ID: 28545735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
